Chutes and Ladders—Lilly’s oncology chief announces retirement

Lilly's oncology chief announced her retirement; a GSK veteran is launching a Chinese public health startup with $260 million; and Gilead's longtime R&D chief is leaving to go back to his roots&md…
Read the full story: FierceBiotech: Biotech